We project the market will grow at a healthy annual rate of 6.4% over the next five years, driven by increasing demand for novel drugs as the global population ages.
LOS ANGELES (PRWEB) November 29, 2018
“The total demand for technologies used in drug discovery reached approximately $4.9 billion in 2017,” said Mike Tice, Senior Vice President of Business Intelligence at SDi. “We project the market will grow at a healthy annual rate of 6.4% over the next five years, driven by increasing demand for novel drugs as the global population ages.”
This report details market activity in the areas of chromatography, sequencing, liquid handling, mass spectrometry, microplate readers, flow cytometry, in vivo animal imaging, high content screening, and capillary electrophoresis. This includes segmentation and 5-year growth by product type, region, and end market. Each section also explores the current state of the competitive playing field, including a list of top vendors’ market shares, a vendor participation matrix, recent developments, and concludes with a short discussion that suggests where the market might be headed over the next five years from the related standpoints of technology, competition, and growth.
The report also features a thorough analysis of a 47-question end-user survey completed by 246 respondents engaged in drug discovery activities from North America, Europe, and Asia. Topics that are explored include instrument usage, vendor usage, industry and regional segmentation, types of activities and assays performed, outsourcing, and budget outlooks.
Supporting the Pipeline: The Market for Instrumentation in Drug Discovery Applications is essential reading for instrumentation companies seeking to understand the dynamics of the important pharmaceutical and biotechnology segments of this market.
About SDi & BioInformatics Inc.
Strategic Directions International (SDi), a leading international management-consulting firm in the highly specialized field of analytical instruments, was acquired by BioInformatics Inc in 2014. The two firms combined to form the premier research and advisory firm serving the life science and analytical instrument industry. By leveraging our verified online professional network of tens of thousands of scientists in The Science Advisory Board®, we have supported more than 500 companies and provided insights that lead to better business decisions. Our expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customers’ brand loyalty, and evaluating brand strength and positioning, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning. SDi and BioInformatics Inc are members of Science and Medicine Group, supporting life science, radiology, dentistry, analytical instrument, and clinical diagnostic companies.
For more information contact:
Senior Vice President of Business Intelligence
Strategic Directions International
A division of BioInformatics Inc.
6242 Westchester Parkway, Suite 100
Los Angeles, CA 90045-4820